10
total announcements
SANOFICONR.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹7,992 Cr
P/E (TTM)
30.0
P/E (Forward)
25.9
EPS (TTM)
₹115.49
52W Low
₹3,455.80
52W High
₹5,255.00
Dividend Yield
2.11%
Beta
0.27
Price / Book
22.9
Return on Equity
87.95%
Debt / Equity
6.0
Revenue (TTM)
₹950 Cr
Gross Margin
74.14%
Operating Margin
36.49%
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, for the purpose of declaration of Unaudited Standalone Financial Results for the quarter and nine months ended 30th September 2026.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has published unaudited financial results for the quarter and half year ended 30th June 2026 in newspapers.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has informed the Exchange regarding a press release dated July 28, 2026, regarding the Unaudited Financial Results for the quarter and half year ended June 30, 2026. The results were approved by the Board of Directors and will be available on the Company's website.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has announced its unaudited financial results for the quarter and half year ended June 30, 2026, which have been approved by the Board of Directors.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has filed a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended 30th June 2026.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Change in Auditors of the company.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has submitted the Exchange a copy Scrutinizer's report of Annual General Meeting held on Jun 26, 2026. Further, the company has informed the Exchange regarding voting results for two resolutions.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has held its 3rd Annual General Meeting (AGM) on June 26, 2026, through video conferencing. The meeting was attended by members, directors, auditors, and other participants. The AGM transacted several items of business, including the adoption of annual audited financial statements, declaration of a final dividend, re-appointment of a director, and appointment of statutory auditors.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has closed its trading window from 1st July 2026 to 48 hours after the announcement of unaudited standalone financial results for the quarter and half year ended 30th June 2026.